US Map / Illinois
State IL

Clinical Trials in Illinois

Illinois is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Illinois and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 398 actively recruiting studies with Illinois sites out of 398 registered in total. The busiest research areas in Illinois are Schizophrenia, Obesity, Breast Cancer. Leading sponsors running trials in the state include University of Chicago, Northwestern University, University of Illinois Chicago. By stage, Illinois trials break down as Phase 1 (55), Phase 2 (104), Phase 3 (106), Phase 4 (15).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
398
Recruiting Now
398
← Back to US Map
Top Conditions in Illinois
Schizophrenia (7)Obesity (7)Breast Cancer (6)Stroke (6)Ovarian Cancer (5)Prostate Cancer (5)Heart Failure (5)Acute Myeloid Leukemia (4)Cancer (4)Cervical Cancer (4)Liver Transplant (4)Ulcerative Colitis (4)

Frequently Asked Questions — Clinical Trials in Illinois

How many clinical trials are currently recruiting in Illinois?
ClinicalMetric currently tracks 398 actively recruiting clinical trials with at least one location in Illinois. The total number of registered studies—including active but not currently enrolling trials—is 398. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Illinois?
Illinois hosts clinical trials across a broad range of medical conditions, including Schizophrenia, Obesity, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Illinois serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Illinois?
To join a clinical trial in Illinois, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Illinois maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Illinois

NCT06312176 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combinatio...
Condition
Breast Neoplasms
Enrollment
1,200 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07090889 Phase 1
Recruiting
Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome.
Condition
Olmsted Syndrome
Enrollment
64 pts
Location
United States, France, United Kingdom
Sponsor
Orvida Pharma (formerly Kamari
View Trial →
NCT06994676 Phase 1
Recruiting
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Condition
High-risk Myelodysplastic Syndrome
Enrollment
72 pts
Location
United States
Sponsor
Crossbow Therapeutics, Inc.
View Trial →
NCT07108387 Phase 2
Recruiting
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Control...
Condition
Giant Cell Arteritis (GCA)
Enrollment
78 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT06284421 N/A
Recruiting
Durometer for Measuring Uterine Tone
Condition
Uterine Tone Disorders
Enrollment
20 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT07723963 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment ...
Condition
Juvenile Myoclonic Epilepsy
Enrollment
260 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT06030063 N/A
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General A...
Condition
Cesarean Delivery
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Yale University
View Trial →
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
NCT06853015 Phase 1, Phase 2
Recruiting
Double Dose 4-AP on Functional Recovery After Spinal Cord Injury
Condition
SCI - Spinal Cord Injury
Enrollment
27 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab
View Trial →
NCT06747117 N/A
Recruiting
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus ...
Condition
Lower Extremity Acute Limb Ischemia
Enrollment
300 pts
Location
United States, Australia, Brazil
Sponsor
Penumbra Inc.
View Trial →
NCT06192576 N/A
Recruiting
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy...
Condition
Niemann-Pick Diseases
Enrollment
10 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT06598150 N/A
Recruiting
Mapping Corticoreticulospinal Motor Control in Chronic Hemiparetic Stroke
Condition
Stroke
Enrollment
32 pts
Location
United States
Sponsor
Northwestern University
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07464925 Phase 1
Recruiting
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Pro...
Condition
Glioblastoma Multiforme of Brain
Enrollment
30 pts
Location
United States
Sponsor
Tetragon Biosciences Ltd
View Trial →
NCT06080789 Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Part...
Condition
Acute Pancreatitis
Enrollment
36 pts
Location
United States, India
Sponsor
Panafina, Inc.
View Trial →
NCT04792489 Phase 2
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
Condition
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Enrollment
315 pts
Location
United States, Canada
Sponsor
Miltenyi Biomedicine GmbH
View Trial →
NCT06551116 N/A
Recruiting
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 i...
Condition
HER2-positive Metastatic Breast Cancer
Enrollment
200 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn
View Trial →
NCT03178149 Phase 1
Recruiting
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losin...
Condition
Age-Related Macular Degeneration
Enrollment
42 pts
Location
United States
Sponsor
Astellas Institute for Regener
View Trial →
NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
View Trial →
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT06270316 Phase 1, Phase 2
Recruiting
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Diseas...
Condition
Fabry Disease
Enrollment
20 pts
Location
United States
Sponsor
UniQure Biopharma B.V.
View Trial →
NCT04181138 N/A
Recruiting
Primary Sclerosing Cholangitis in Children
Condition
Primary Sclerosing Cholangitis
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
View Trial →
NCT06750094 Phase 3
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in P...
Condition
Colorectal Neoplasms
Enrollment
700 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT06663722 Phase 2
Recruiting
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Gra...
Condition
Chronic Graft Versus Host Disease
Enrollment
49 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradioth...
Condition
Urothelial Cancer
Enrollment
390 pts
Location
United States, Canada, South Korea
Sponsor
Astellas Pharma Global Develop
View Trial →
Page 6 of 16 — 398 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology